Phosphodiesterase Inhibitors as Therapeutics for Traumatic Brain Injury
Journal:
Current Pharmaceutical Design
Volume:
21
Page:
332-342
Author(s):
David J. Titus, Anthony A. Oliva, Nicole M. Wilson and Coleen M. Atkins
The Roles of Phosphodiesterase 2 in the Central Nervous and Peripheral Systems
Journal:
Current Pharmaceutical Design
Volume:
21
Page:
274-290
Author(s):
Chong Zhang, Yingcong Yu, Lina Ruan, Chuang Wang, Jianchun Pan, Jonathan Klabnik, Lindsay Lueptow, Han-Ting Zhang, James M. O’Donnell and Ying Xu
Phosphodiesterase: An Interface Connecting Cognitive Deficits to Neuropsychiatric and Neurodegenerative Diseases
Journal:
Current Pharmaceutical Design
Volume:
21
Page:
303-316
Author(s):
Zhen-Zhen Wang, Yi Zhang, Han-Ting Zhang and Yun-Feng Li
Editorial (Thematic Issue: Targeting Phosphodiesterases (PDEs) for Treatment of CNS Diseases)
Journal:
Current Pharmaceutical Design
Volume:
21
Page:
271-273
Author(s):
Han-Ting Zhang
Poly (D,L-Lactide-co-Glycolide) Nanoparticles Loaded with Cerebrolysin Display Neuroprotective Activity in a Rat Model of Concussive Head Injury
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
13
Page:
1475-1482
Author(s):
Barbara Ruozi, Daniela Belletti, Flavio Forni, Aruna Sharma, Dafin Muresanu, Herbert Mossler, Maria A. Vandelli, Giovanni Tosi and Hari S. Sharma
The Implications of Sortilin/Vps10p Domain Receptors in Neurological and Human Diseases
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
13
Page:
1354-1365
Author(s):
Cornelia M. Wilson, Thomas Naves, Sofiane Saada, Sandra Pinet, Francois Vincent, Fabrice Lalloue and Marie-Odile Jauberteau
The Neuroprotective Mechanism of Erythropoietin-TAT Fusion Protein Against Neurodegeneration from Ischemic Brain Injury
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
13
Page:
1465-1474
Author(s):
Ping Liu, Xiaolei Liu, Anthony Kian-Fong Liou, Juan Xing, Zheng Jing, Xunming Ji, Xiangrong Liu, Haiping Zhao, Feng Yan, Jun Chen, Guodong Cao and Yumin Luo
Inflammation in Ischemic Stroke: Mechanisms, Consequences and Possible Drug Targets
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
13
Page:
1378-1396
Author(s):
Muzamil Ahmad, Nawab J. Dar, Zubair S. Bhat, Aehtesham Hussain, Ayatullah Shah, Hao Liu and Steven H. Graham
Conference Report: 12th International Congress on Neuroprotective Agents (ICNA), Charlottesville, VA, USA September 28, 2014-Ocobert 01, 2014
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
13
Page:
1308-1309
Author(s):
Hari S. Sharma, Stephen D. Skaper and Aruna Sharma
Targeted Drug Delivery to Central Nervous System (CNS) for the Treatment of Neurodegenerative Disorders: Trends and Advances
Journal:
Central Nervous System Agents in Medicinal Chemistry
Volume:
14
Page:
43-59
Author(s):
Kritika Goyal, Veena Koul, Yashveer Singh and Akshay Anand